Summary (tl;dr)

Over 3 million bottles of various eye drops manufactured by K.C. Pharmaceuticals have been voluntarily recalled nationwide due to a "lack of assurance of sterility," meaning the products cannot be confirmed as free from contamination.

Essential Background

Sterility is a critical safety requirement for eye care products as they are applied directly to the eye, bypassing the body's natural defenses. Recalls of eye drops typically occur when there are concerns about contamination, unsanitary manufacturing conditions, or when a manufacturer cannot guarantee the product's sterility, which can pose a risk of infection or other adverse health effects to users.

The Full Story

K.C. Pharmaceuticals, Inc., based in Pomona, California, voluntarily initiated a recall of approximately 3.1 million bottles of various eye drop products in early March, with the U.S. Food and Drug Administration (FDA) classifying it as a Class II recall on March 31, 2026. The recall stems from a "lack of assurance of sterility," indicating that the company cannot guarantee its manufacturing processes prevented microbial contamination. The affected products, which include artificial tears, advanced relief, and redness relief formulas, were sold under numerous labels at major retailers across the United States, including Walgreens, CVS, Kroger, H-E-B, Rite Aid, and others, with many having expiration dates extending into 2026.

Why It Matters

This recall is significant because non-sterile eye drops pose a potential risk of eye infections and other temporary or medically reversible adverse health consequences, although the FDA classifies the risk of serious harm as remote. Consumers are actively searching for information to determine if products in their medicine cabinets are affected. Health officials are urging individuals to immediately stop using the recalled eye drops and to check product labels and lot numbers, especially those with codes beginning with AC, AR, LT, SU, RG, RL, SY, or AT and 2026 expiration dates. Anyone experiencing symptoms such as eye pain, redness, or vision changes after using these products should contact a healthcare provider.

Geographic Location

• Pomona, Los Angeles County, California, United States (location of K.C. Pharmaceuticals, Inc., the manufacturer of the recalled eye drops)
• United States (nationwide distribution of recalled eye drops)